ETC
Exchange Traded Concepts’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $800K | Buy |
25,365
+484
| +2% | +$15.3K | 0.01% | 754 |
|
|
2025
Q1 | $815K | Buy |
24,881
+2,762
| +12% | +$90.5K | 0.01% | 638 |
|
|
2024
Q4 | $800K | Buy |
22,119
+560
| +3% | +$20.3K | 0.02% | 654 |
|
|
2024
Q3 | $672K | Buy |
+21,559
| New | +$672K | 0.02% | 699 |
|
|
2024
Q1 | – | Sell |
-42,189
| Closed | -$1.22M | – | 1417 |
|
|
2023
Q4 | $1.22M | Buy |
42,189
+335
| +0.8% | +$9.7K | 0.03% | 360 |
|
|
2023
Q3 | $1.15M | Buy |
41,854
+26,390
| +171% | +$728K | 0.03% | 353 |
|
|
2023
Q2 | $465K | Sell |
15,464
-510
| -3% | -$15.3K | 0.01% | 627 |
|
|
2023
Q1 | $579K | Sell |
15,974
-3,964
| -20% | -$144K | 0.02% | 513 |
|
|
2022
Q4 | $711K | Buy |
19,938
+540
| +3% | +$19.3K | 0.02% | 378 |
|
|
2022
Q3 | $657K | Sell |
19,398
-74
| -0.4% | -$2.51K | 0.02% | 332 |
|
|
2022
Q2 | $563K | Buy |
19,472
+444
| +2% | +$12.8K | 0.02% | 462 |
|
|
2022
Q1 | $615K | Sell |
19,028
-27,607
| -59% | -$892K | 0.01% | 517 |
|
|
2021
Q4 | $1.36M | Buy |
46,635
+813
| +2% | +$23.7K | 0.03% | 296 |
|
|
2021
Q3 | $1.22M | Buy |
45,822
+9,717
| +27% | +$259K | 0.03% | 288 |
|
|
2021
Q2 | $1.11M | Buy |
36,105
+3,433
| +11% | +$106K | 0.04% | 301 |
|
|
2021
Q1 | $855K | Buy |
32,672
+4,362
| +15% | +$114K | 0.03% | 316 |
|
|
2020
Q4 | $712K | Buy |
28,310
+2,760
| +11% | +$69.4K | 0.03% | 277 |
|
|
2020
Q3 | $532K | Buy |
25,550
+4,414
| +21% | +$91.9K | 0.03% | 289 |
|
|
2020
Q2 | $502K | Buy |
+21,136
| New | +$502K | 0.08% | 210 |
|